Publications
Detailed Information
Social functioning and quality of life as measures of effectiveness in the treatment of schizophrenia
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kwon, Jun Soo | - |
dc.contributor.author | Choi, Jung-Seok | - |
dc.date.accessioned | 2012-07-05T01:33:50Z | - |
dc.date.available | 2012-07-05T01:33:50Z | - |
dc.date.issued | 2009-02 | - |
dc.identifier.citation | WORLD PSYCHIATRY; Vol.8(1); 35-36 | ko_KR |
dc.identifier.issn | 1723-8617 | - |
dc.identifier.uri | https://hdl.handle.net/10371/78544 | - |
dc.description.abstract | From the perspective of health care
practitioners, the most useful clinical trials are those that assess the effectiveness of a drug, that is, determine how well the drug works under conditions of actual clinical practice. Clinical trials designed to determine effectiveness should use outcome measures that have the greatest clinical significance for practitioners, with the goal of maximizing generalizability and addressing practical questions about the risks, benefits, and costs of an intervention in routine clinical practice (1). Here we would like to emphasize the importance of social functioning and quality of life (QOL) as outcome variables in clinical trials in patients with schizophrenia. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | ELSEVIER MASSON | ko_KR |
dc.title | Social functioning and quality of life as measures of effectiveness in the treatment of schizophrenia | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 권준수 | - |
dc.contributor.AlternativeAuthor | 최정석 | - |
dc.citation.journaltitle | WORLD PSYCHIATRY | - |
dc.description.citedreference | Kane J, 2007, SCHIZOPHR RES, V90, P147, DOI 10.1016/j.schres.2006.09.012 | - |
dc.description.citedreference | Jones PB, 2006, ARCH GEN PSYCHIAT, V63, P1079 | - |
dc.description.citedreference | Strakowski SM, 2005, SCHIZOPHR RES, V78, P161, DOI 10.1016/j.schres.2005.04.017 | - |
dc.description.citedreference | Ritsner M, 2004, J CLIN PSYCHOPHARM, V24, P582, DOI 10.1097/01.jcp.0000144895.75728.2b | - |
dc.description.citedreference | Mortimer A, 2004, INT CLIN PSYCHOPHARM, V19, P63, DOI 10.1097/01.yic.0000115713.96925.ba | - |
dc.description.citedreference | Rosenheck R, 2003, JAMA-J AM MED ASSOC, V290, P2693 | - |
dc.description.citedreference | Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624 | - |
dc.description.citedreference | Montes JM, 2003, PROG NEURO-PSYCHOPH, V27, P667, DOI 10.1016/S0278-5846(03)00077-0 | - |
dc.description.citedreference | Merlo MCG, 2002, J CLIN PSYCHIAT, V63, P885 | - |
dc.description.citedreference | ENDICOTT J, 1993, PSYCHOPHARMACOL BULL, V29, P321 | - |
dc.description.citedreference | HEINRICHS DW, 1984, SCHIZOPHRENIA BULL, V10, P388 | - |
dc.description.tc | 4 | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.